Physician profile
Keith Anacker
NPI 1750906798
$2,058.06
in general payments reported to CMS, 2019-2025
11 companies · $1,632 in 2025
The $1,632 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $61.15 · 2024: $364 · 2025: $1,632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,683.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,682.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $921.88 | 2025 | Accolade Sr, Cds Broad Portfolio Offering, General - Therapies |
| E.R. Squibb & Sons, L.L.C. | $404.13 | 2025 | Camzyos, Eliquis |
| Atricure, INC. | $98.29 | 2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
| Kestra Medical Technology Services, INC. | $73.22 | 2025 | Assure Wcd |
| Irhythm Technologies, INC. | $50.56 | 2024 | Zio Monitor, Zio Xt Patch |
| Bayer Healthcare Pharmaceuticals INC. | $37.00 | 2025 | |
| Novo Nordisk INC | $31.07 | 2025 | Wegovy |
| Merck Sharp & Dohme LLC | $18.97 | 2025 | Verquvo |
| Alnylam Pharmaceuticals INC. | $18.21 | 2025 | Onpattro |
| Bridgebio Pharma, INC. | $16.08 | 2025 | Attruby |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.57 | 2025 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Anacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.